NOT KNOWN FACTUAL STATEMENTS ABOUT SEVITERONEL

-mutated tumors. However, merely a fraction of those people responds to immune checkpoint or PARP inhibitors and in some cases those who do react normally create resistance and relapse.Differential consequences on AR and AR targets with enzalutamide and seviteronel procedure. AR+ TNBC cells ended up handled with five μM enzalutamide or seviteronel